IMAGE GUIDED THERAPY CENTER
影像引导治疗中心
基本信息
- 批准号:8363231
- 负责人:
- 金额:$ 310.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAreaBiomedical EngineeringClinicalClinical InvestigatorCollaborationsCommitCommunitiesDevelopmentDrug Delivery SystemsFocused Ultrasound TherapyFundingFutureGoalsGrantHospitalsImageInterdisciplinary StudyInterventionMagnetic Resonance ImagingMetabolicMethodsMissionNational Center for Research ResourcesOperative Surgical ProceduresPrincipal InvestigatorProstateResearchResearch InfrastructureResourcesRoboticsScientistServicesSiteSourceTechnologyTestingTherapeuticTrainingTranslational ResearchUnited States National Institutes of HealthWomanbiomedical resourceclinical applicationclinical infrastructureclinically relevantcostimage guided therapyinnovationinnovative technologiesmolecular imagingmultidisciplinaryneurosurgerynew technologynovelprogramspublic health relevancetechnology development
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
DESCRIPTION (provided by applicant): We are requesting continuation of funds for the National Biomedical Resource Center in Image-guided Therapy (NCIGT) at the Brigham & Women's Hospital. The Center provides a unique, centralized infrastructure for translational research in the area of image-guided therapy. The multidisciplinary program involves clinical investigators, biomedical engineers, and basic scientists in promoting and advancing IGT methods and related innovative clinical applications. We will develop and make available new, clinically relevant technologies in six discrete TRD Core Projects: 1) Computational Core; 2) Imaging Core; 3) Image- Guidance Core; 4) Neurosurgery Core; 5) Prostate Core and 6) Focused Ultrasound Therapy Core. These key research initiatives represent the technical and clinical infrastructure of the Resource. They are anticipated to have significant effect on several future IGT methods and clinical applications. We will combine forces with 7 independently funded Collaborations (DBPs) that address various essential technical or clinical aspects of IGT and our contribution will have significant clinical impact. Our goal is to combine current advances in the field of imaging (like Molecular Imaging, Functional and Metabolic Imaging) with advanced therapies (like MRI-guided Focused Ultrasound ablation or targeted drug delivery, endoscopic surgery or robotics) to achieve less invasive, safer and more effective therapeutic options. All IGT developments and applications will be tested and validated either on our site or at our collaborators, or distributed directly as a service to the growing IGT community. Our overarching goal is to continue being the leading National Center that reaching effectively across a broad range of constituencies through service, training and dissemination of the novel technologies and methods under development in this Resource.
PUBLIC HEALTH RELEVANCE: The overarching impetus for this application is to advance and propagate novel image-guided therapy technologies, effectively producing strengthened multidisciplinary research efforts and an infrastructure commensurate with sophisticated technology development. We are also committed to making our technology broadly available to a large community of clinician. Our mission is to develop and implement novel, innovative technologies to decrease the invasiveness of surgeries and interventions.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
子项目的主要研究者可能是由其他来源提供的,
包括其它NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
NCRR赠款不直接向子项目或子项目工作人员提供资金。
描述(由申请人提供):我们要求继续为布里格姆妇女医院的国家生物医学资源中心提供图像引导治疗(NCIGT)资金。该中心提供了一个独特的,集中的基础设施,在图像引导治疗领域的转化研究。该多学科计划涉及临床研究人员,生物医学工程师和基础科学家,以促进和推进IGT方法和相关的创新临床应用。我们将在六个独立的TRD核心项目中开发和提供新的临床相关技术:1)计算核心; 2)成像核心; 3)图像引导核心; 4)神经外科核心; 5)前列腺核心和6)聚焦超声治疗核心。这些关键的研究举措代表了资源的技术和临床基础设施。预计它们将对未来的几种IGT方法和临床应用产生重大影响。我们将联合收割机力量与7个独立资助的合作(DBP),解决IGT的各种基本技术或临床方面,我们的贡献将产生重大的临床影响。我们的目标是将联合收割机目前成像领域的进展(如分子成像、功能和代谢成像)与先进的治疗(如MRI引导的聚焦超声消融或靶向药物输送、内窥镜手术或机器人)相结合,以实现侵入性更小、更安全、更有效的治疗选择。所有IGT开发和应用程序都将在我们的网站或我们的合作伙伴处进行测试和验证,或直接作为服务分发给不断增长的IGT社区。我们的总体目标是继续成为领先的国家中心,通过服务,培训和传播本资源中正在开发的新技术和方法,有效地覆盖广泛的选区。
公共卫生相关性:这一应用的总体动力是推进和传播新的图像引导治疗技术,有效地加强多学科的研究工作和与先进技术发展相称的基础设施。我们还致力于使我们的技术广泛提供给广大的临床医生社区。我们的使命是开发和实施新颖的创新技术,以减少手术和干预的侵入性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ferenc A Jolesz其他文献
CORTICAL BRAIN DEVELOPMENT IN PRETERM AND FULLTERM INFANTS: SURFACE AND VOLUME CHANGES MEASURED BY 3D-MRI • 1733
早产儿和足月儿的大脑皮质发育:通过 3D-MRI 测量的表面和体积变化•1733
- DOI:
10.1203/00006450-199704001-01752 - 发表时间:
1997-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Petra S Huppi;Simon Warfield;Richard J Taranto;Stephen A Ringer;Ferenc A Jolesz;Joseph J Volpe - 通讯作者:
Joseph J Volpe
Cerebral Perinatal White Matter Injury of the Preterm Infant Alters Subsequent Microstructural Brain Development
- DOI:
10.1203/00006450-199904020-02038 - 发表时间:
1999-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Petra S Huppi;Terrie E Inder;Stephan E Maier;Gary P Zientara;Brendan Murphy;Ferenc A Jolesz;Joseph J Volpe - 通讯作者:
Joseph J Volpe
Periventricular White Matter Injury in the Premature Infant Is Associated with a Reduction in Cerebral Cortical Gray Matter Volume at Term
- DOI:
10.1203/00006450-199904020-02039 - 发表时间:
1999-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Terrie E Inder;Petra S Huppi;Simon Warfield;Ron Kikinis;Gary P Zientara;Patrick D Barnes;Ferenc A Jolesz;Joseph J Volpe - 通讯作者:
Joseph J Volpe
Quantitative Assessment of Brain Development in Multiple Gestation Babies using in vivo 3-dimensional-MRI (3D-MRI) 116
使用体内三维磁共振成像(3D-MRI)对多胎妊娠婴儿脑发育的定量评估 116
- DOI:
10.1203/00006450-199609000-00139 - 发表时间:
1996-09-01 - 期刊:
- 影响因子:3.100
- 作者:
Petra S Hüppl;Miles K Tsuji;Patrick Barnes;Ron Kikinis;Ferenc A Jolesz;Joseph J Volpe - 通讯作者:
Joseph J Volpe
ASSESSMENT OF NEWBORN BRAIN MICROSTRUCTURE USING DIFFUSION WEIGHTED MR-IMAGING (DWI): EARLY DETECTION OF PERIVENTRICULAR LEUKOMALACIA (PVL)† 908
使用扩散加权磁共振成像(DWI)评估新生儿脑微结构:脑室周围白质软化症(PVL)的早期检测†908
- DOI:
10.1203/00006450-199704001-00927 - 发表时间:
1997-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Petra S Huppi;Stephan E Maier;Sharon Peled;Stephen Ringer;Ferenc A Jolesz;Joseph J Volpe - 通讯作者:
Joseph J Volpe
Ferenc A Jolesz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ferenc A Jolesz', 18)}}的其他基金
Ultrasound-induced blood-brain/tumor barrier disruption in brain metastases
脑转移中超声诱导的血脑/肿瘤屏障破坏
- 批准号:
8506197 - 财政年份:2013
- 资助金额:
$ 310.68万 - 项目类别:
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
MRI 引导聚焦超声用于药物输送和脑肿瘤消融
- 批准号:
8475981 - 财政年份:2013
- 资助金额:
$ 310.68万 - 项目类别:
NCIGT Workshop on Future Directions in Image-Guided Therapy
NCIGT 图像引导治疗未来方向研讨会
- 批准号:
8412977 - 财政年份:2010
- 资助金额:
$ 310.68万 - 项目类别:
NCIGT Workshop on Future Directions in Image-Guided Therapy
NCIGT 图像引导治疗未来方向研讨会
- 批准号:
8215877 - 财政年份:2010
- 资助金额:
$ 310.68万 - 项目类别:
NCIGT Workshop on Future Directions in Image-Guided Therapy
NCIGT 图像引导治疗未来方向研讨会
- 批准号:
8041064 - 财政年份:2010
- 资助金额:
$ 310.68万 - 项目类别:
NCIGT Workshop on Future Directions in Image-Guided Therapy
NCIGT 图像引导治疗未来方向研讨会
- 批准号:
7674991 - 财政年份:2010
- 资助金额:
$ 310.68万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 310.68万 - 项目类别:
Research Grant